Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Translational Gastroenterology and Hepatology|April 13, 2019
Update on systemic therapy for colorectal cancer: biologics take sidesOlumide Gbolahan, Bert O'NeilExpert Opinion on Investigational Drugs|December 31, 2013
GI-4000 in KRAS mutant cancersSafi Shahda, Bert O'NeilExpert Opinion on Investigational Drugs|June 25, 2009
Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment optionsJanine Marie Davies, Bert O'NeilClinical Advances in Hematology & Oncology : H&O|April 9, 2008
Targeted therapies for hepatocellular carcinomaMatthew R Skelton, Bert O'NeilThe Oncologist|April 12, 2013
Antiangiogenic therapies for advanced hepatocellular carcinomaKeeran R Sampat, Bert O'NeilWorld Journal of Gastrointestinal Oncology|December 23, 2015
Targeted therapy for advanced gastric cancer: A review of current status and future prospectsOzkan Kanat, Bert O'Neil, Safi ShahdaJournal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational BurdenOlumide Gbolahan, Neda Hashemi-Sadraei, Bert O'NeilBMC Cancer|May 19, 2019
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective studyOlumide B Gbolahan, Yan Tong, Amikar Sehdev, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
The proteasome as a target for cancer therapyPeter M Voorhees, E Claire Dees, Bert O'Neil, et al.Oncology|March 22, 2012
HER2/neu may not be an interesting target in biliary cancers: results of an early phase II study with lapatinibJoshua Peck, Lai Wei, Mark Zalupski, et al.Pageof 5